Digital Dentistry is an emerging technology in dental field, which will enhance patient’s treatment modality in future. It provides digital equipment available to cosmetic dentists and implant dentists. Digital dentistry is not a wave of future, its occurring now. Whether a dentist embraces a new technology will define his/her practice and possibly future. The purpose of this article is to examine the concept of digital dentistry, its advantages and limitations and make statements and observations in specific areas of digital dentistry based on research. The success of incorporating a new technology in dental office is dependent on the knowledgebase of not only the dentist but the entire dental team.

The rising incidence of breast cancer in Ghana calls for urgent national intervention to ensure prevention and treatment. There is therefore the need for actionable research in Ghana to find preventive remedies to reduce the rate. The Breast being the priciest assets of women also benefits men if it is in good health. This paper examines the development of a natural product that has undergone clinical trials at the Kwame Nkrumah University of Science and Technology (KNUST) at Kumasi-Ashanti region in Ghana. Animal model was employed for the clinical trials. The product formulated by Dr. Raphael Nyarkotey Obu and Manufactured by RNG Medicine Research Laboratory in Ghana contains the Hibiscus Sabdarifa and Zingiber officinale as the ingredients. The product has the brand name ‘Women’s Formula Tea’ with batch number 01D19 for breast health, weight loss, low libido and general wellbeing support. RNG introduced bioenergization into the plant to increase its shelf life, reduce microbial loads and improve its efficacy. The Faculty of Pharmacy and Pharmaceutical Sciences of the University employed three diverse trials for the product (in a tea form of thirty (30) bags) conducted through Department of Pharmaceutics to assess the microbial loads, the Department of Pharmacology to assess the efficacy, acute and Sub chronic Toxicity test and the Department of Pharmacognosy also assess the phytochemical and Physicochemical properties of the formulation. These are the protocols needed and if passed, to be sent to the Food and Drug Authority for certification. The formulator’s dosage is three bags three times for those with breast disorders and one daily for maintenance of breast health. The result revealed that Women’s Formula Herbal Tea has antioxidant activity and hence detoxifying ability and kidney protective function. The OAEL is greater than three times the stated daily dosage indicated by the manufacturer. The recommended dose is thus within acceptable margin of safety.

Very often you find elderly men in Ghana above 40 years complaining of a feebleurinarystream, urgency, incomplete voiding et al. These observations are on the increase with no preventive measures to reverse the trend. Prostatic diseases have become a huge national burden and affecting the quality of life in men. It is in line with this that the researcher formulated this novel breakthrough prostate product in Ghana to deal with the rising cases. This paper therefore examines the development of a natural prostatic diseases product that has undergone clinical trials at the Kwame Nkrumah University of Science and Technology (KNUST) in Kumasi-Ashanti region in Ghana. Animal model was employed for the clinical trials. The product formulated by Dr. Raphael Nyarkotey Obu and Manufactured by RNG Medicine Research Laboratory in Ghana, is in two phases: the first stage contains two plants; Hibiscus sabdariffa and Croton Membranaceus. The second phase which is the most important stage contains twelve (12) plants based ingredients for RNG Holistic Hospital and Prostate Research Lab which is currently undergoing clinical trials at the same facility. This paper therefore focuses on the first phase of the trials with Hibiscus sabdariffa and Croton membranaceus which have passed the clinical trials. The product has the brand name ‘Men’s Formula Herbal Tea’ with batch number 01D19 for the management of prostatic disorders and promoting healthy prostate support. The product is developed with three models of attack: promoting urinary health, balancing prostate hormones and improving quality of life (QOL) of the prostate patient with superior science. The plants are organ specific, bioenergized and locally grown. The Faculty of Pharmacy and Pharmaceutical Sciences of the University employed three diverse trials for the product which comes as a tea with content in thirty tea-bags (30). The trails were conducted through the Department of Pharmaceutics to assess the microbial loads, the Department of Pharmacology to assess the efficacy, acute and Sub chronic Toxicity test. Lastly, the Department of Pharmacognosy also assessed the phytochemical and Physicochemical properties of the formulation. These are the protocols needed and if successful, to be sent to the Food and Drug Authority for certification. The formulator’s dosage is two bags x 3 daily for prostatic disorders and one daily for reducing risk of prostate disease or maintaining its health. The result revealed that, on total antioxidant activity; the product-Men’s Formula Herbal Tea (0.3-10.0mg/ml), showed an increase in total antioxidant capacity expressed as ascorbic acid equivalent. The total antioxidant capacity of ascorbic (0.01-0.3mg/ml)increased with increasing concentration (r2=0.9922). On reducing power, Men’s Formula Herbal Tea (0.1-3mg ml-1) and the standard antioxidant-tocopherol (0.1-3mlmg-1) dose dependently reduced Fe3+ to Fe2+ as indicated by a dose-dependent increase in absorbance. From EC50(in mg ml-1) obtained for Men’s Formula Herbal Tea(10.4 ± 1.42) and tocopherol (18.18 ± 4.29). The remarks states that, as per the findings, men’s formula Herbal Tea has antioxidant activity and hence would be of significantly relevant in prostate disorders. The No-Observable-Adverse-Effect level (OAEL) is greater than three times the stated daily dosage (7.0ml/kg) indicated by the manufacturer. The recommended daily dose is thus within the acceptable margin of safety.

This paper examines the development of a natural hypertensive product that has undergone clinical trials at the Kwame Nkrumah University of Science and Technology (KNUST) at Kumasi-Ashanti region in Ghana. Animal model was employed for the clinical trials. The product formulated by Dr. Raphael Nyarkotey Obu and Manufactured by RNG Medicine Research Laboratory in Ghana contains the Hibiscus Sabdarifa as a single ingredient. The product has the brand name ‘Dr. Nyarkotey Tea’ with batch number 01D19 for the management of Hypertension, diabetic conditions and support for general wellbeing. RNG introduced bioenergization into the plant to increase its shelf life, reduce microbial loads and improve its efficacy. The Faculty of Pharmacy and Pharmaceutical Sciences of the University employed three diverse trials for the product (in a tea form of thirty (30) bags) conducted through Department of Pharmaceutics to assess the microbial loads, the Department of Pharmacology to assess the efficacy, acute and Sub chronic Toxicity test and the Department of Pharmacognosy, to assess the phytochemical and Physicochemical properties of the formulation. These are the protocols needed and if passed to be sent to the Food and Drug Authority for certification. The formulator’s dosage is two bags twice (x2) daily for diabetics and hypertensive patients. The product Dr. Nyarkotey Herbal Tea produced dose-dependent reduction in the arterial blood pressure of the anaesthetized cat comparable to acetylcholine. The depressor effects of acetylcholine and Dr. Nyarkotey Herbal tea on the blood pressure of the anaesthetized cat were inhibited by 72.3+5.21% and 55.6 + 6.82% respectively, suggestive of muscarinic mediation. The remarks states that, as per the findings, Dr. Nyarkotey Herbal Tea has hypotension effect and hence could be used in the management of hypotension. The No-Observable-Adverse-Effect level (OAEL) is greater than five times the stated daily dosage (7.0ml/kg) indicated by the manufacturer. The recommended daily dose is thus within the acceptable margin of safety.

Aim: Prostate cancer is more aggressive in men of African descent than men of other races. There are lots of disparities in prostate cancer yet most men in the black communities are not aware of the disease let alone go in for screening programs. In Ghana, it is stated that the county has reached the global prostate limit. This review explores the trend and focus of cancer of the prostate research activities in Ghana as one of the ancestral nations for black men. It seeks to locate the place of the Ghanaian research environment in the global progress on prostate cancer disparities. Method: Extensive Literature was reviewed mainly through a Pub med search with the terms "prostate cancer “and "Ghana", as well as from internet, Ghanaian newspapers and hard copies of journal pages. Result: The countries largest men’s charity, men’s health foundation Ghana states that 1 in 5 Ghanaian men will get prostate cancer in their lifetime. Prostate cancer in Ghanaian men is on the rise with little or no governmental effort to fight it. Conclusion: The global focus on prostate cancer disparities in black men calls for more efforts from Africa, in all areas of research, along with international collaborations for capacity building. Prostate NGO’s in Ghana needs serious funding in other to help fight the disease in Ghana.